Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India

被引:0
|
作者
Jaya Singh Kshatri
Debdutta Bhattacharya
Srikanta Kanungo
Sidhartha Giri
Subrata Kumar Palo
Debaprasad Parai
Jyotirmayee Turuk
Asit Mansingh
Hari Ram Choudhary
Matrujyoti Pattnaik
Girish Chandra Dash
Prasantajyoti Mohanty
Niranjan Mishra
Durga Madhab Satapathy
Sanjaya Kumar Sahoo
Sanghamitra Pati
机构
[1] ICMR-Regional Medical Research Centre,Department of Health and Family Welfare
[2] Government of Odisha,Department of Community Medicine
[3] Maharaja Krushna Chandra Gajapati Medical College and Hospital,undefined
来源
Scientific Reports | / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
This was a population based cross-sectional study carried out to estimate and compare the seroprevalence, hidden prevalence and determine the demographic risk factors associated with SARS-CoV-2 infection among adults in the three largest cities of Odisha, India, and ascertain the association with the progression of the epidemic. The survey carried out in August 2020 in the three largest cities of the state of Odisha, India. Blood samples were collected from the residents using random sampling methods and tested for anti- SARS CoV-2 antibodies using an automated CLIA platform. A total of 4146 participants from the 3 cities of Bhubaneswar (BBS), Berhampur (BAM) and Rourkela (RKL) participated. The female to male participation ratio was 5.9:10 across the three cities. The gender weighted seroprevalence across the three cities was 20.78% (95% CI 19.56–22.05%). While females reported a higher seroprevalence (22.8%) as compared to males (18.8%), there was no significant difference in seroprevalence across age groups. A majority of the seropositive participants were asymptomatic (90.49%). The case to infection ratio on the date of serosurvey was 1:6.6 in BBS, 1:61 in BAM and 1:29.8 in RKL. The study found a high seroprevalence against COVID-19 in urban Odisha as well as high numbers of asymptomatic infections. The epidemic curves had a correlation with the seroprevalence.
引用
收藏
相关论文
共 50 条
  • [31] Executive deficits after SARS-CoV-2 infection: A cross-sectional population study
    Buer, S.
    Hagen, B. I.
    Soraas, A.
    White, R. A.
    Bo, R.
    Ellingjord-Dale, M.
    Istre, M. S.
    Brunvoll, S. H.
    Lerdal, A.
    Landro, N. I.
    Nygaard, A. B.
    Stubberud, J.
    BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2024, 41
  • [32] SARS-CoV-2 infection among primary healthcare workers: a cross-sectional study
    Qotba, Hamda Abdulla A.
    Hamed, Ehab
    Alnuaimi, Ahmed Sameer
    Saad, Azza Awad
    Nasrallah, Gheyath K.
    Alnaama, Abdulla Abdulrahman
    Syed, Mohamed Ahmed
    GERMS, 2021, 11 (02): : 324 - 328
  • [33] A cross-sectional overview of SARS-CoV-2 genome variations in Turkey
    Ergunay, Koray
    Kaya, Mucahit
    Serdar, Muhittin
    Akyon, Yakut
    Yilmaz, Engin
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2021, 46 (05): : 491 - 498
  • [34] Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
    Sorg, Anna-Lisa
    Bergfeld, Leon
    Jank, Marietta
    Corman, Victor
    Semmler, Ilia
    Goertz, Anna
    Beyerlein, Andreas
    Verjans, Eva
    Wagner, Norbert
    Von Bernuth, Horst
    Lander, Fabian
    Weil, Katharina
    Hufnagel, Markus
    Spiekerkoetter, Ute
    Chao, Cho-Ming
    Naehrlich, Lutz
    Muntau, Ania Carolina
    Schulze-Sturm, Ulf
    Hansen, Gesine
    Wetzke, Martin
    Jung, Anna-Maria
    Niehues, Tim
    Fricke-Otto, Susanne
    Von Both, Ulrich
    Huebner, Johannes
    Behrends, Uta
    Liese, Johannes G.
    Schwerk, Christian
    Drosten, Christian
    Von Kries, Ruediger
    Schroten, Horst
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [35] Genomic profiles of vaccine breakthrough SARS-CoV-2 strains from Odisha, India
    Ghosh, Arup
    Walia, Safal
    Rattan, Roma
    Kanampalliwar, Amol
    Jha, Atimukta
    Aggarwal, Shifu
    Fatma, Sana
    Das, Niyati
    Chayani, Nirupama
    Prasad, Punit
    Raghav, Sunil K.
    Parida, Ajay
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 119 : 111 - 113
  • [36] Incidence and severity of SARS-CoV-2 virus post COVID-19 vaccination: A cross-sectional study in India
    Selvaraj, Preethi
    Muthu, Sathish
    Jeyaraman, Naveen
    Prajwal, Gollahalli Shivashankar
    Jeyaraman, Madhan
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2022, 14
  • [37] Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
    Anna-Lisa Sorg
    Leon Bergfeld
    Marietta Jank
    Victor Corman
    Ilia Semmler
    Anna Goertz
    Andreas Beyerlein
    Eva Verjans
    Norbert Wagner
    Horst Von Bernuth
    Fabian Lander
    Katharina Weil
    Markus Hufnagel
    Ute Spiekerkoetter
    Cho-Ming Chao
    Lutz Naehrlich
    Ania Carolina Muntau
    Ulf Schulze-Sturm
    Gesine Hansen
    Martin Wetzke
    Anna-Maria Jung
    Tim Niehues
    Susanne Fricke-Otto
    Ulrich Von Both
    Johannes Huebner
    Uta Behrends
    Johannes G. Liese
    Christian Schwerk
    Christian Drosten
    Ruediger Von Kries
    Horst Schroten
    Nature Communications, 13
  • [38] Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys
    Larremore, Daniel B.
    Fosdick, Bailey K.
    Bubar, Kate M.
    Zhang, Sam
    Kissler, Stephen M.
    Metcalf, C. Jessica E.
    Buckee, Caroline O.
    Grad, Yonatan H.
    ELIFE, 2021, 10
  • [39] The paramount importance of serological surveys of SARS-CoV-2 infection and immunity
    Jaap Goudsmit
    European Journal of Epidemiology, 2020, 35 : 331 - 333
  • [40] The paramount importance of serological surveys of SARS-CoV-2 infection and immunity
    Goudsmit, Jaap
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2020, 35 (04) : 331 - 333